Evidence map›Paper›PMID 42232484›Full record

ReviewExploratory research in clinical and social pharmacy2026

Pharmacist independent prescribing in Middle Eastern countries: Insights from a systematic review of awareness, readiness, and barriers to implementation.

Farah Kais Alhomoud

Abstract readReview
In one paragraph

Review in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Farah Kais AlhomoudDepartment of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, the Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Independent Prescribing Practice (IPP) by pharmacists has been internationally recognized as an effective strategy to improve healthcare access, optimize medication use, and reduce physician workload. This review aimed to examine pharmacists' awareness, readiness, attitudes systematically, and perceived barriers and facilitators toward implementing IPP in selected Middle Eastern countries. Methods: A systematic review followed the PRISMA 2020 guidelines for conducting and reporting systematic reviews and the Cochrane Handbook guidelines. PubMed, Web of Science, regional journals, and the grey literature published between 2015 and 2025 was systematically searched using predefined keywords related to pharmacist prescribing. Eligible studies were quantitative, peer-reviewed (qualitative studies were excluded), and focused on pharmacists' readiness or perceptions of IPP in the Middle East. Data on study characteristics, awareness, readiness, barriers, and facilitators were extracted and synthesized descriptively. Results: Nine cross-sectional studies from Saudi Arabia, Jordan, and the United Arab Emirates (UAE), involving pharmacists, were included in this analysis. Pharmacists demonstrated high readiness and positive attitudes toward IPP, acknowledging its potential to enhance patient access and improve healthcare efficiency. However, implementation remains limited by the absence of legal frameworks, insufficient diagnostic training, and weak interprofessional collaboration. Identified facilitators included national health reforms, professional development initiatives, and institutional support for expanding clinical roles. Conclusion: Pharmacists in Saudi Arabia, Jordan, and the UAE demonstrate readiness to adopt independent prescribing; however, evidence is limited to these countries and cannot be generalized to the wider Middle East. Structural, regulatory, and educational barriers persist, highlighting the need for context-specific policy and training frameworks.

Indexed as

Extended pharmacy serviceIndependent prescribingMiddle EastPharmacists

Identifiers

PMID42232484
PMCPMC13223846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.